Portage Biotech Inc. (PRTG) Misses Q4 EPS by 161c
Tweet
Share
E-mailGet Alerts PRTG Hot Sheet
Join SI Premium – FREE
Portage Biotech Inc. (NASDAQ: PRTG) reported Q4 EPS of ($1.88), $1.61 worse than the analyst estimate of ($0.27).
For earnings history and earnings-related data on Portage Biotech Inc. (PRTG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ackman adds Netflix, Visa and Mastercard in portfolio revamp
- Euroseas Ltd. (ESEA) Tops Q2 EPS by 61c
- Ascendis Pharma (ASND) Tops Q2 EPS by 132c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
